Updates in Treatment of Recurrent Clostridium difficile Infection
| Autor: | Tanveer Singh, Prabhjot Singh Bedi, Susmitha Seelam, Manoj P Rai, Jeevandeep Singh, Karandeep Bumrah |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
genetic structures business.industry Recurrent Clostridium difficile Review General Medicine Fecal bacteriotherapy Clostridium difficile Pharmacological treatment Fecal microbiota transplantation 03 medical and health sciences Tapering and pulsed vancomycin 0302 clinical medicine Treatment modality Medicine Healthcare cost 030211 gastroenterology & hepatology Fidaxomicin 030212 general & internal medicine business Intensive care medicine medicine.drug |
| Zdroj: | Journal of Clinical Medicine Research |
| ISSN: | 1918-3011 1918-3003 |
| DOI: | 10.14740/jocmr3854 |
| Popis: | Recurrent Clostridium difficile infection (CDI) is a perpetual problem that leads to increased economic burden, higher healthcare cost, and significant morbidity and mortality. Its treatment remains a challenge. While various treatment approaches have been attempted with different levels of success, robust data establishing the superiority of one approach over the others is lacking. In this article, we review the current evidence pertaining to conventional pharmacological treatment as well as fecal microbiota transplantation (FMT) as a novel, rapidly emerging treatment modality for recurrent CDI. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|